Compare SYY & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYY | HLN |
|---|---|---|
| Founded | 1969 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Food Distributors | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9B | 42.8B |
| IPO Year | 2004 | 2021 |
| Metric | SYY | HLN |
|---|---|---|
| Price | $83.72 | $10.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $91.08 | $11.93 |
| AVG Volume (30 Days) | 3.3M | ★ 15.8M |
| Earning Date | 11-03-2026 | 07-30-2026 |
| Dividend Yield | ★ 2.68% | 1.98% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.66 | N/A |
| Revenue | ★ $84,553,000,000.00 | N/A |
| Revenue This Year | $6.48 | $3.30 |
| Revenue Next Year | $2.27 | $4.18 |
| P/E Ratio | ★ $22.45 | $49.05 |
| Revenue Growth | ★ 3.91 | N/A |
| 52 Week Low | $68.19 | $8.65 |
| 52 Week High | $91.85 | $11.28 |
| Indicator | SYY | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 71.40 |
| Support Level | $82.33 | $9.63 |
| Resistance Level | $85.05 | $10.64 |
| Average True Range (ATR) | 1.32 | 0.16 |
| MACD | 0.68 | 0.13 |
| Stochastic Oscillator | 98.72 | 98.13 |
Sysco is the largest foodservice distributor in the US, with an 18% share of the $377 billion vertical. The firm sells and distributes over 500,000 food and nonfood products to about 730,000 customer locations, primarily serving restaurants, which represented 60% of fiscal 2025 sales. The balance of sales stems from healthcare facilities (8%), education and government customers (8%), travel and leisure clients (7%), and other smaller end markets (17%), like cafeterias. By segment, Sysco earns the bulk of its revenue from its US foodservice operations (70%), followed by its international footprint (18%), SYGMA, which focuses on quick-service logistics (10%), and other (2%). The pending Jetro Restaurant Depot deal stands to add $16 billion in sales upon close, expected in fiscal 2027.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.